Sumitomo Pharma Co. Ltd.

PNK: DNPUF · Real-Time Price · USD
5.80
1.70 (41.46%)
At close: May 01, 2025, 9:30 AM

Sumitomo Pharma Revenue

Sumitomo Pharma reported an annual revenue of $314.56B, reflecting a -43.38% growth. For the quarter ending June 30, 2024, Sumitomo Pharma generated $90.67B in revenue.
Revenue (ttm)
$314.56B
Revenue Growth
-43.38%
Price / Sales Ratio
0.5
Revenue / Employee
$63.16M
Employees
4,980
Market Cap
2.3B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Mar 31, 2024 314.56B -43.38%
Mar 31, 2023 555.54B -0.80%
Mar 31, 2022 560.03B +8.54%
Mar 31, 2021 515.95B +6.88%
Mar 31, 2020 482.73B n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.